This will calm the farm. A very good report indeed.
# Revenues nearly trebled from PCP while personnel costs actually went down.
# Gross Margin 49%....Magnificent margins for a startup.....Their pharmaceuticals has the highest margins of 52%.
# +ve cash flow after investing $1.3 to double manufacturing capacity to $57m.
# $3.3m EBITDA +ve.
# Strong working capital.....Working Capital doubled to $5m from the June half...... Well funded internally.
Add to My Watchlist
What is My Watchlist?
